Telemedicine Helped Ensure Essential Type 2 Diabetes Care Amid the COVID-19 Pandemic

A new study from the University of Eastern Finland indicates that the COVID-19 pandemic has seriously affected healthcare service usage among patients with 2 type diabetes in North Karelia, Finland, but essential care was continuously provided. The delivery of many essential services was facilitated by processes that strongly relied on telemedicine already before the pandemic.

The outbreak of COVID-19 has challenged healthcare systems and their ability to deliver essential health services. While social distancing measures avoided spreading the virus, they conflicted with good diabetes management, which requires regular follow-up visits to manage the disease and its complications.

In Finland, the government imposed a national lockdown on 16 March, lasting until mid-May 2020. This study used electronic health records to compare healthcare usage in the region of North Karelia in three different periods in 2020 - before, during, and after the lockdown - with the equivalent period in 2019.

In 2020, type 2 diabetes patients sought significantly fewer diabetes- and dental health-related primary healthcare services than the year before the pandemic, with the most significant reduction during the lockdown period. Emergency visits in specialized care dropped significantly during the lockdown period as well, but quickly recovered during the post-lockdown period, reaching the same volume as in 2019.

The high proportion of patients using remote services for diabetes management cushioned the drastic decline in face-to-face appointments - also among elderly patients aged 70 years or older. The proportion of remote consultation among all diabetes-related contacts increased from 56% before the pandemic to 88% during the lockdown period in 2020. Therefore, overall contacts were only 9% fewer in 2020 compared with 2019, while appointments halved.

"The pandemic has highlighted the importance of digital healthcare solutions," says Early Stage Researcher Laura Inglin from the University of Eastern Finland. "In Finland, patients have been able to receive new prescriptions, referrals for examinations, medical opinions, self-care instructions, and lifestyle guidance to monitor and control long-term diseases remotely already for some time. That was a great asset during the pandemic."

"Another asset of Finnish healthcare are high-quality electronic health records, which provide structured and up-to-date information about patients at the point of care. Using routine care data for research helps advance our collective knowledge of health system response to pandemics for future preparedness," Inglin points out.

Inglin L, Wikström K, Lamidi ML, Laatikainen T.
The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland.
BMC Health Serv Res. 2022 Jun 1;22(1):725. doi: 10.1186/s12913-022-08105-z

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...